| Literature DB >> 26467757 |
Izabel Cristina Gomes de Mendonça1, Isabel Cristina Celerino de Moraes Porto2, Ticiano Gomes do Nascimento3, Naiana Soares de Souza4, José Marcos dos Santos Oliveira5, Rodolfo Elleson dos Santos Arruda6, Kristiana Cerqueira Mousinho7, Aldenir Feitosa dos Santos8, Irinaldo Diniz Basílio-Júnior9, Abhishek Parolia10, Francisco Stefânio Barreto11.
Abstract
BACKGROUND: The implementation of new public healthcare models that stimulate the use of natural products from traditional medicine, as a so-called integrated medicine, refers to an approach that use best of both conventional medicine and traditional medicine. Propolis is a widely used natural product by different ancient cultures and known to exhibit biological activities beneficial for health. The large number of studies conducted with propolis had shown that its chemical composition differs as a function of the climate, plant diversity and bee species and plays an important role on its therapeutic properties. The aim of this study was to analyse the phytochemical profile of the ethanolic extract of red propolis (EEP) and its fractionation, antioxidant action of EEP and its fractions hexane, cloroform and ethyl acetate and cytotoxic activity of EEP on human tumour cell lines SF-295 (glioblastoma), OVCAR-8 (ovary) and HCT-116 (colon).Entities:
Mesh:
Substances:
Year: 2015 PMID: 26467757 PMCID: PMC4604764 DOI: 10.1186/s12906-015-0888-9
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
In vitro assessment of Brazilian red propolis cytotoxicity
| IC50 (μg/mL) | |||
|---|---|---|---|
| Cells | |||
| HCT-116 | SF-295 | OVCAR-8 | |
| EEP | ~25.26 | 34.27 (24.28 – 48. 37) | 28.76 (24.42 – 33.87) |
| Doxorubicin | 0.12 (0.09 – 0.17) | 0.24 (0.2 – 0.27) | 0.26 (0.17 – 0.30) |
Assessment of both Brazilian red propolis extract (EEP) and Doxorubicin cytotoxicity (MTT assay) 72 h after incubation with three tumour cell lines. IC50 and 95 % confidence interval - CI (μg/mL) calculated based on the mean and corresponding standard deviation of the mean and determined through non-linear regression
Fig. 1Cell viability 72 h after exposure to various EEP concentrations. Cell survival is expressed as a percentage relative to the negative control (DMSO). EEP at a concentration of 50 μg/mL, exhibited cytotoxic activity against HCT-116 and OVCAR-8 cells, without a significant difference compared with the positive control (0.5 μM doxorubicin). Compared with the other two cell lines, SF-295 cells exposed to EEP at a concentration of 50 μg/mL exhibited a significantly higher survival rate compared with those exposed to doxorubicin. Each bar graph represents the mean, and the error bars represent ± SD of three independent experiments performed in triplicate
Phytochemical screening of the red propolis extract
| Allelochemical | EEP | Chloroform fraction | Ethyl acetate fraction | Hexane fraction |
|---|---|---|---|---|
| Phenols | Na | N | N | N |
| Pyrogallic tannins | N | N | N | N |
| Phlobaphene tannins | Pa | P | P | P |
| Anthocyanin and anthocyanidin | N | N | N | N |
| Flavones, flavonols and xanthones | P | P | N | P |
| Chalcones and aurones | P | P | P | N |
| Flavononols | N | N | N | N |
| Leucoanthocyanidins | N | N | N | N |
| Catechins | P | P | P | N |
| Flavonones | N | N | N | N |
| Steroids | N | N | N | N |
| Triterpenoids | P | P | P | P |
| Saponins | N | N | N | N |
Phytochemical screening detected presence of phlobaphene tannins, flavones, flavonols, xanthones and pentacyclic triterpenoids in EEP and its chloroform, hexane and ethyl acetate fractions
a P positive, N negative
Fig. 2Concentration of phenolic compounds in mg of gallic acid equivalents/g of extract detected in EEP and fractions diluted in hexane, chloroform and ethyl acetate. The highest values corresponded to the chloroform fraction
Antioxidant activity (%AOA) of EEP and its fractions
| Concentration (μg/mL) / (%AOA) | |||||||
|---|---|---|---|---|---|---|---|
| 25.0 | 15.0 | 10.0 | 5.0 | 2.5 | 1.0 | IC50 (μg/ml) | |
| EEP | 86.57 | 73.43 | 64.18 | 38.51 | 25.97 | 11.34 | 8.01 |
| hexane fraction | 90.42 | 87.04 | 76.62 | 49.00 | 44.22 | 18.87 | 5.15 |
| chloroform fraction | 86.86 | 84.18 | 69.55 | 47.16 | 41.19 | 16.79 | 5.20 |
| ethyl acetate fraction | 88.73 | 76.90 | 59.44 | 34.93 | 24.79 | 11.27 | 6.01 |
| Trolox | 68.30 | 50.02 | 28.00 | 12.98 | 6.07 | 3.02 | 14.68 |
Free radical DPPH sequestering activity (%) of the ethanolic extract of Brazilian red propolis and its hexane, chloroform and ethyl acetate fractions
Fig. 3Chromatogram of EEP obtained by means of LC-Orbitrap-FTMS
Identification and confirmation of biomarkers of Brazilian red propolis in EEP using LC-Orbitrap-FTMS
| Peak | m/z | RT (min) | Formulae | Compound |
|---|---|---|---|---|
| 1 | 179.0556 | 2.95 | C9H8O4 | Caffeic acid |
| 2 | 193.0502 | 2.98 | C10H10O4 | Ferulic acid |
| 3 | 179.0556 | 3.00 | C9H8O4 | Umbelic acid |
| 4 | 163.0243 | 3.04 | C9H8O3 | p-Coumaric acid |
| 5 | 475.1232 | 3.10 | C23H24O11 | 7-O-beta-glucopyranosyl-4′-hydroxy-5-methoxyisoflavone |
| 6 | 461.1073 | 4.50 | C22H22O11 | 6-Methoxyluteolin 7-rhamnoside |
| 7 | 269.0811 | 7.05 | C15H10O5 | Genistein |
| 8 | 285.0395 | 7.35 | C15H10O5 | Kaempferol |
| 9 | 289.0711 | 8.04 | C15H14O6 | Cathechin |
| 10 | 287.0553 | 8.28 | C15H12O6 | Dalbergioidin |
| 11 | 289.0711 | 8.83 | C15H14O6 | Epicatechin |
| 12 | 253.0499 | 8.95 | C15H10O4 | Daidzein |
| 13 | 255.0655 | 9.7 | C15H12O4 | Liquiritigenin |
| 14 | 283.0603 | 10.5 | C16H12O5 | 2′-Hydroxyformononetin |
| 15 | 331.0810 | 11.3 | C17H16O7 | Evernic acid |
| 16-17 | 271.0605 | 11.9 | C15H12O5 | Naringenin |
| Pinobanksin | ||||
| 18 | 283.0604 | 12.4 | C16H12O5 | Calycosin |
| 19 | 255.0656 | 13.4 | C15H12O4 | Isoliquiritigenin |
| 20-21 | 267.0656 | 13.8 | C16H12O4 | Formononetin |
| Isoformononetin | ||||
| 22 | 269.0812 | 14.2 | C16H14O4 | 4,4′-dihydroxy-2-methoxychalcone |
| 23 | 269.0812 | 14.2 | C16H14O4 | (7S)-dalbergiphenol |
| 24 | 271.0969 | 14.7 | C16H16O4 | Vestitol |
| 25 | 269.0813 | 15.1 | C16H14O4 | Pinostrobin |
| 26 | 269.0813 | 15.1 | C16H14O4 | Medicarpin |
| 27 | 255.0657 | 16.2 | C15H12O4 | 2′,6′-dihydroxy-4′-methoxydihydrochalcone |
| 28 | 255.0657 | 16.2 | C15H12O4 | Thevetiaflavone |
| 29 | 539.1699 | 17.0 | C32H28O8 | 3′,4′-di-O-benzyl-7-O-(2-hydroxyethyl)-3-O-methylquercetin |
| 30-31 | 285.1131 | 18.2 | C17H18O4 | (3S)-7-O-methylvestitol |
| 7,3′-Dihydroxy-4′-methoxy-8-methylflavane | ||||
| 32-34 | 425.1603 | 21.4 | C30H50O | Cycloartenol |
| α-amyrin | ||||
| β-amyrin | ||||
| 35-37 | 601.3533 | 32.9 | C38H50O6 | Guttiferone E |
| Guttiferone F | ||||
| Xantochymol | ||||
| 38-39 | 669.4156 | 39.2 | C43H58O6 | Guttiferone C |
| Guttiferone D | ||||
| 40 | 401.3058 | 48.4 | C26H42O3 | 19-nor-10-keto-25-hydroxyvitamin D3 |